SpotitEarly, an early cancer detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples, today announced a strategic partnership with the Fox Chase Cancer ...

Fox Chase Cancer Center will lead clinical testing of a New Jersey startup's AI and dog-powered breath test for early lung ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min His departure leaves Fox Chase ...

Fox Chase Cancer Center's Dr. Randall Lee joined 'Fox & Friends First' to discuss why cancer diagnosis rates are on the rise, what contributes to the trend and the benefits of a post-Thanksgiving meal ...

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for side effects. Now new research by Fox Chase Cancer Center physicians shows ...

Corinne Van Hoven grew up wanting to be an oncologist, motivated by the loss of her grandfather to prostate cancer on her 7th birthday. “It was a scary and confusing time for a little girl,” she said.

SpotitEarly Announces Strategic Partnership With Fox Chase Cancer Center, Bolstering the Validity of Its Breakthrough Early Cancer Detection Technology The Collaboration Includes Clinical Trials as ...

Fox Chase becomes the first NCI-designated Comprehensive Cancer Center to implement clinical testing utilizing Arima's 3D-genomics technology in multiple tumor types as part of a standard protocol.